Jianerkang Medical Co., Ltd. (SHA:603205)
China
· Delayed Price · Currency is CNY 39.98
+0.90 (2.30%)
At close: May 15, 2025, 2:57 PM CST
Jianerkang Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | 124.07 | 120.22 | 123.55 | 157.34 | 131.63 | 384.26 | Upgrade
|
| Depreciation & Amortization | 42.49 | 42.49 | 40.95 | 36.84 | 32.41 | 6.59 | Upgrade
|
| Other Amortization | 2.35 | 2.35 | 1.62 | 1.55 | 1.52 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.43 | -0.43 | -0.03 | 3.02 | -0.13 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.07 | 0.07 | 0.07 | 0.07 | 0.12 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.74 | -0.74 | 16.19 | -0.1 | -0.35 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.48 | -0.48 | 5.95 | 14.55 | -5.5 | - | Upgrade
|
| Other Operating Activities | -25.58 | 3.78 | 0.98 | -3.29 | 7.29 | 122.69 | Upgrade
|
| Change in Accounts Receivable | 14.95 | 14.95 | -36.93 | -83.11 | -2.32 | - | Upgrade
|
| Change in Inventory | -25.19 | -25.19 | 7.31 | -17.25 | 9.65 | - | Upgrade
|
| Change in Accounts Payable | -21.68 | -21.68 | -0.9 | 46.08 | -107.28 | - | Upgrade
|
| Change in Other Net Operating Assets | 4.8 | 4.8 | -2.65 | 6.13 | 5.52 | - | Upgrade
|
| Operating Cash Flow | 115.59 | 141.1 | 157.8 | 163.01 | 70.6 | 513.54 | Upgrade
|
| Operating Cash Flow Growth | -29.09% | -10.59% | -3.20% | 130.90% | -86.25% | 466.13% | Upgrade
|
| Capital Expenditures | -40.81 | -39.75 | -84.18 | -66.32 | -48.64 | -143.49 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.98 | 2.98 | 0.15 | 0.21 | 0.19 | 0.01 | Upgrade
|
| Other Investing Activities | -104.06 | 0.26 | -16.19 | 0.1 | 0.41 | 10.25 | Upgrade
|
| Investing Cash Flow | -141.89 | -36.51 | -83.92 | -66.01 | -48.04 | -133.22 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 120 | 50 | 171.47 | Upgrade
|
| Total Debt Issued | - | - | - | 120 | 50 | 171.47 | Upgrade
|
| Short-Term Debt Repaid | - | - | -30 | -140 | -69.47 | -563.27 | Upgrade
|
| Total Debt Repaid | - | - | -30 | -140 | -69.47 | -563.27 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -30 | -20 | -19.47 | -391.8 | Upgrade
|
| Issuance of Common Stock | 412.55 | 412.55 | - | - | 3 | 88.2 | Upgrade
|
| Common Dividends Paid | - | - | -0.69 | -1.66 | -2.1 | -113.32 | Upgrade
|
| Other Financing Activities | -24.96 | -25.1 | -2 | -2.9 | - | 47.85 | Upgrade
|
| Financing Cash Flow | 387.59 | 387.45 | -32.69 | -24.57 | -18.57 | -369.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.77 | 3.53 | 4.92 | 10.35 | -2.56 | -3.93 | Upgrade
|
| Net Cash Flow | 364.06 | 495.57 | 46.11 | 82.79 | 1.42 | 7.32 | Upgrade
|
| Free Cash Flow | 74.78 | 101.35 | 73.62 | 96.7 | 21.96 | 370.05 | Upgrade
|
| Free Cash Flow Growth | -22.67% | 37.66% | -23.86% | 340.34% | -94.07% | 1048.16% | Upgrade
|
| Free Cash Flow Margin | 6.96% | 9.69% | 7.12% | 8.85% | 2.81% | 22.79% | Upgrade
|
| Free Cash Flow Per Share | 0.73 | 1.07 | 0.82 | 1.07 | 0.24 | 4.62 | Upgrade
|
| Cash Income Tax Paid | - | -37.42 | -48.17 | - | - | 123.11 | Upgrade
|
| Levered Free Cash Flow | - | 55.45 | 12.35 | 32.97 | -46.43 | 248.94 | Upgrade
|
| Unlevered Free Cash Flow | - | 55.45 | 12.76 | 34 | -45.13 | 256.29 | Upgrade
|
| Change in Net Working Capital | - | 29.85 | 28.14 | 33.18 | 99.05 | -22.96 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.